RVP (Retractable Technologies) 10-Year RORE % : -5.29% (As of Mar. 2026)


RVP Retractable Technologies Inc RVP
35 GF Score
Price $0.69
GF Value $0.77
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Retractable Technologies 10-Year RORE %?

Retractable Technologies RVP -1.36% 35 10-Year RORE % is -5.29 as of Mar. 2026. GuruFocus rates RVP with a GF Score™ of 35/100 and a GF Value™ of $0.77 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 428 Medical Devices & Instruments companies, Retractable Technologies ranks worse than 60.98% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Retractable Technologies's 10-Year RORE % for the quarter that ended in Mar. 2026 was -5.29%.

The industry rank for Retractable Technologies's 10-Year RORE % or its related term are showing as below:

RVP's 10-Year RORE % is ranked worse than
60.98% of 428 companies
in the Medical Devices & Instruments industry
Industry Median: 0.735 vs RVP: -5.29

Retractable Technologies  (AMEX:RVP) 10-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 10-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Retractable Technologies 10-Year RORE % Related Terms


Retractable Technologies 10-Year RORE % Historical Data

* Premium members only.

The historical data trend for Retractable Technologies's 10-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Retractable Technologies 10-Year RORE % Chart

Retractable Technologies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
10-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 101.68 19.25 -5.81 -32.88 -21.86

Retractable Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
10-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -62.78 -18.73 -13.19 -21.86 -5.29

RVP vs ZJYL, HBIO, RGNT: 10-Year RORE % Comparison

For the Medical Instruments & Supplies subindustry, Retractable Technologies's 10-Year RORE %, along with its competitors' market caps and 10-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Retractable Technologies 10-Year RORE % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Retractable Technologies's 10-Year RORE % distribution charts can be found below:

* The bar in red indicates where Retractable Technologies's 10-Year RORE % falls into.


RVP
35GF Score
Retractable Technologies Inc RVP
10-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Retractable Technologies 10-Year RORE % Calculation

Retractable Technologies's 10-Year RORE % for the quarter that ended in Mar. 2026 is calculated as:

10-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 10-year -Cumulative Dividends per Share for 10-year )
=( -0.21--0.15 )/( 1.135-0 )
=-0.06/1.135
=-5.29 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 10-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 10-year before.

Frequently Asked Questions Learn more about 10-Year RORE % →
What does a 10-Year RORE % of -5.29 mean?
Retractable Technologies (RVP) has a 10-Year RORE % of -5.29 as of Mar. 2026. 10-Year RORE % shows how much a company earns by reinvesting its retained earnings in 10-year. View historical data on Retractable Technologies and its competitors. According to the industry distribution chart, Retractable Technologies ranks #261 out of 428 companies in the Medical Devices & Instruments industry, placing it in the top 61%.
Is Retractable Technologies' 10-Year RORE % too high?
Retractable Technologies' current 10-Year RORE % is -5.29. Based on the distribution chart, Retractable Technologies ranks #261 out of 428 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Retractable Technologies has a GF Score™ of 35/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Retractable Technologies' 10-Year RORE % compare to ZJYL and HBIO?
According to the Medical Devices & Instruments industry distribution chart, Retractable Technologies ranks #261 out of 428 companies for 10-Year RORE %. This places Retractable Technologies in the lower half of its industry. The industry median 10-Year RORE % is 0.74. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 10-Year RORE % for a Medical Devices & Instruments company?
The median 10-Year RORE % among Medical Devices & Instruments companies is 0.74, based on 428 companies in the industry. Companies in the top quartile (top 25%) have a 10-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 10-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 10-Year RORE % mean?
A high 10-Year RORE % can signal that a stock is expensive relative to its fundamentals. 10-Year RORE % shows how much a company earns by reinvesting its retained earnings in 10-year. View historical data on Retractable Technologies and its competitors. For the Medical Devices & Instruments industry, the median 10-Year RORE % is 0.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Retractable Technologies's current 10-Year RORE % is -5.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Retractable Technologies stock overvalued right now?
Based on GuruFocus' analysis, Retractable Technologies (RVP) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.77, compared to a current price of $0.69 — trading 10.2% below its estimated fair value. The current 10-Year RORE % is -5.29. Retractable Technologies' overall GF Score™ is 35/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 10-Year RORE % calculated?
10-Year RORE % is calculated from a company's financial statements. For Retractable Technologies (RVP), the current 10-Year RORE % is -5.29 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Retractable Technologies (RVP) Overvalued in 2026?

Based on GuruFocus' analysis, Retractable Technologies stock appears to be undervalued. The current stock price of $0.69 is trading 10.2% below its estimated GF Value™ of $0.77. GuruFocus considers Retractable Technologies to be Modestly Undervalued.

Key valuation signals for RVP:

  • 10-Year RORE %: -5.29
  • GF Value™: $0.77 vs. price of $0.69 (10.2% below fair value)
  • GF Score™: 35/100 with 3 warning signs

No single metric tells the full story. See the RVP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Retractable Technologies Business Description

Address 511 Lobo Lane, Little Elm, TX, USA, 75068-5295
Retractable Technologies Inc is engaged in the manufacturing and marketing of safety medical products (predominantly syringes) for the healthcare industry. It has manufacturing facilities in Little Elm, Texas, and uses manufacturers in China as well. Its syringes are well-suited for administering vaccinations. The company's products are VanishPoint Syringe, VanishPoint Insulin Syringes, EasyPoint Needle, EasyPoint Blood Collection Tube with Needle, VanishPoint Blood Collection Set, and VanishPoint IV Catheter. It provides solutions such as Insulin, Immunization, Blood Collection, Allergy, General Purpose, and Infusion.
35GF Score

Get the complete analysis for RVP

10-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.69
Price
$0.77
GF Value